Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

20.240
-0.780-3.71%
Volume:3.44M
Turnover:69.67M
Market Cap:25.46B
PE:-126.29
High:20.820
Open:20.820
Low:20.020
Close:21.020
52wk High:21.500
52wk Low:12.310
Shares:1.26B
HK Float Shares:1.26B
Volume Ratio:0.53
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.160
ROE:-29.99%
ROA:-15.93%
PB:5.76
PE(LYR):-126.29
PS:7.35

Loading ...

Zai Lab Announces Participation in UBS and Jefferies Investor Conferences

Reuters
·
Yesterday

Zai Lab Announces Participation in Investor Conferences in November 2026

THOMSON REUTERS
·
Yesterday

Zai Lab Says ZL-1503 was Well Tolerated with no Serious Adverse Events

Reuters
·
Nov 13

Zai Lab - Zl-1503 Well Tolerated with no Serious Adverse Events or Anti-Drug Antibodies Detected

THOMSON REUTERS
·
Nov 13

Zai Lab Reports Sustained Biomarker Inhibition with ZL-1503 in Phase 1 Trial

Reuters
·
Nov 13

Movement Alert|ZAI LAB Falls 4.38% in Regular Trading, 7.1 Million Share Issuance Under Share Plan Draws Dilution Focus

Market Focus
·
Nov 13

Zai Lab Issues 7.1 Million Shares Under Its Share Plan

Stock News
·
Nov 12

Asian Equities Traded in the US as American Depositary Receipts Advance Sharply in Monday Trading

MT Newswires Live
·
Nov 09

Hong Kong Stock Connect Biotech Rebounds: Zai Lab Surges 12% as Huabao Innovative Drug ETF Breaks Above 120-Day Line

Deep News
·
Nov 09

Zai Lab Shares Surge Over 12% in Morning Trading as Q3 Product Revenue Hits US$107.6 Million, Up 2% Sequentially

Deep News
·
Nov 09

China Cranks Out New Drugs. How to Play It.

Dow Jones
·
Nov 07

Zai Lab Ltd Reports Results for the Quarter Ended September 30 - Earnings Summary

Reuters
·
Nov 06

Zai Lab's Zoci Shows 40% Response Rate in Trial of Previously Treated Extrapulmonary Neuroendocrine Cancers

Reuters
·
Nov 05

Zai Lab Expects Return to Meaningful Revenue Growth in 2027

Reuters
·
Nov 05

Zai Lab Posts 3Q 2026 Net Loss of USD 46.14 Million as Product Sales Dip 7%; Cash on Hand at USD 659.66 Million Ahead of USD 241.20 Million Private Placement Inflow

Bulletin Express
·
Nov 05

Zai Lab Q3 2026 Revenue Reaches $108.2 Million

Stock News
·
Nov 05

Zai Lab Q3 2026 Net Loss Widens 28% Year on Year to $46.14 Million

Reuters
·
Nov 05

Zai Lab - Q3 2026 Net Loss $46.10 Mln, Loss Per Share $0.04, Loss Per Ads $0.41

THOMSON REUTERS
·
Nov 05

Zai Lab - Q3 2026 Total Revenue $108.20 Mln vs $116.10 Mln in Q3 2025

THOMSON REUTERS
·
Nov 05

Zai Lab Announces Third Quarter 2026 Financial Results and Recent Corporate Updates

THOMSON REUTERS
·
Nov 05